POTASSIUM CHLORIDE FOR ORAL SOLUTION

N/A

Manufactured by Ajenat Pharmaceuticals LLC

88 FDA adverse event reports analyzed

Last updated: 2026-04-14

About POTASSIUM CHLORIDE FOR ORAL SOLUTION

POTASSIUM CHLORIDE FOR ORAL SOLUTION is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Ajenat Pharmaceuticals LLC. The most commonly reported adverse reactions for POTASSIUM CHLORIDE FOR ORAL SOLUTION include COMPLETED SUICIDE, NAUSEA, CARDIAC ARREST, DIARRHOEA, RESPIRATORY ARREST. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for POTASSIUM CHLORIDE FOR ORAL SOLUTION.

Top Adverse Reactions

COMPLETED SUICIDE19 reports
NAUSEA6 reports
CARDIAC ARREST5 reports
DIARRHOEA5 reports
RESPIRATORY ARREST4 reports
TOXICITY TO VARIOUS AGENTS4 reports
ABDOMINAL PAIN3 reports
MEDICATION ERROR3 reports
DRUG ABUSE2 reports
HEADACHE2 reports
HOT FLUSH2 reports
HYPERKALAEMIA2 reports
PAIN2 reports
ABDOMINAL DISCOMFORT1 reports
ABDOMINAL DISTENSION1 reports
ABDOMINAL PAIN UPPER1 reports
ACUTE MYOCARDIAL INFARCTION1 reports
BLOOD GLUCOSE INCREASED1 reports
BLOOD PRESSURE INCREASED1 reports
BRADYCARDIA1 reports
DRUG INEFFECTIVE1 reports
ELECTROCARDIOGRAM ABNORMAL1 reports
INCORRECT ROUTE OF DRUG ADMINISTRATION1 reports
INFLAMMATORY BOWEL DISEASE1 reports
INTENTIONAL OVERDOSE1 reports
JOINT SWELLING1 reports
LOSS OF CONSCIOUSNESS1 reports
MOUTH SWELLING1 reports
OVERDOSE1 reports
PARAESTHESIA1 reports
PNEUMONIA1 reports
POISONING DELIBERATE1 reports
QUADRIPLEGIA1 reports
REACTION TO COLOURING1 reports
RESPIRATORY DEPRESSION1 reports
SNEEZING1 reports
SPINAL CORD PARALYSIS1 reports
SUICIDE ATTEMPT1 reports
TACHYCARDIA1 reports
TOOTH DISCOLOURATION1 reports
VOMITING1 reports
WHITE BLOOD CELL COUNT INCREASED1 reports

Report Outcomes

Out of 50 classified reports for POTASSIUM CHLORIDE FOR ORAL SOLUTION:

Serious 64.0%Non-Serious 36.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female32 (64.0%)
Male17 (34.0%)
Unknown1 (2.0%)

Reports by Age

Age 704 reports
Age 513 reports
Age 573 reports
Age 603 reports
Age 653 reports
Age 392 reports
Age 452 reports
Age 532 reports
Age 772 reports
Age 802 reports
Age 261 reports
Age 301 reports
Age 361 reports
Age 381 reports
Age 411 reports
Age 521 reports
Age 541 reports
Age 551 reports
Age 631 reports
Age 661 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with POTASSIUM CHLORIDE FOR ORAL SOLUTION?

This profile reflects 88 FDA FAERS reports that mention POTASSIUM CHLORIDE FOR ORAL SOLUTION. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for POTASSIUM CHLORIDE FOR ORAL SOLUTION?

Frequently reported terms in FAERS include COMPLETED SUICIDE, NAUSEA, CARDIAC ARREST, DIARRHOEA, RESPIRATORY ARREST, TOXICITY TO VARIOUS AGENTS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures POTASSIUM CHLORIDE FOR ORAL SOLUTION?

Labeling and FAERS entries often list Ajenat Pharmaceuticals LLC in connection with POTASSIUM CHLORIDE FOR ORAL SOLUTION. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.